Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)

Historical Holders from Q3 2020 to Q3 2025

Symbol
ACET on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
154M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
51.3M
Holdings value
$41.6M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
53
Number of buys
24
Number of sells
-17
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ORBIMED ADVISORS LLC 9.6% $12M 14.8M ORBIMED ADVISORS LLC 08 Oct 2025
TANG CAPITAL MANAGEMENT LLC 9.9% $6.21M 8.22M TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025

Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 51.3M $41.6M -$36.6K $0.81 53
2025 Q2 51.6M $31.5M -$3.11M $0.61 47
2025 Q1 55.9M $42M -$1.43M $0.76 56
2024 Q4 57.6M $55.4M -$613K $0.96 61
2024 Q3 57.1M $82.3M -$8.52M $1.44 62
2024 Q2 64M $77.4M -$24M $1.21 83
2024 Q1 75.1M $177M +$98.2M $2.35 96
2023 Q4 33.4M $63M -$3.18M $1.89 76
2023 Q3 35.7M $48.9M -$4.18M $1.37 83
2023 Q2 37.1M $90.2M -$28.2M $2.43 92
2023 Q1 40.2M $231M -$1.58M $5.76 105
2022 Q4 42.1M $377M -$18.2M $8.94 100
2022 Q3 41.7M $592M +$53.4M $14.22 98
2022 Q2 37.9M $553M +$48.5M $14.60 97
2022 Q1 33M $659M +$43.1M $19.97 82
2021 Q4 30.4M $531M +$191M $17.49 78
2021 Q3 19.9M $156M -$14.7M $7.84 54
2021 Q2 21.2M $218M +$7.95M $10.29 60
2021 Q1 20.3M $266M +$141M $13.08 50
2020 Q4 9.54M $134M +$6.73M $14.05 39
2020 Q3 9.05M $108M +$108M $11.89 28